2023 Grand Rounds - Preventative Genomics: The Path to Universal Sequencing - The Dr. Julius M. and Marjorie R. Kantor Endowed Lectureship

Thursday, September 21, 2023, 8:00 AM - 9:00 AM, Online

Click here to join the presentation from your laptop or computer.

Local and national leaders present pediatric topics in their area of specialty during this weekly series. 

This is our annual Dr. Julius M. and Marjorie R. Kantor Endowed Lectureship

Objective(s): 1 Explore the current state of genomics research and its potential to improve human health through personalized and preventative medicine. 1 Assess whether follow up was appropriate or exaggerated for babies identified with unanticipated monogenic disease risk findings in the BabySeq Project. 2 Discuss the arguments for and against population based genetic screening. 3 Identify the percentages of healthy adults and infants who carry unanticipated monogenic disease risks or atypical pharmacogenomic variants as observed in the MedSeq and BabySeq projects. 4 Explain the difference between indication-based genetic testing and predictive genetic testing. 5 Describe the actions taken for both infants and their families in the BabySeq Project based on unanticipated monogenic disease risks.
Location: Online
Specialties: Anesthesiology, Dental Clinic, Family Practice, Graduate Medical Education, Internal Medicine/Pediatrics, Ophthalmology, Orthopaedics, Pathology/Clinical Labs, Pediatrics, Radiology, Research, Surgery, All Specialties

Faculty Disclosures:
Robert C. Green, MD, MPH (Paid consultant-Allelica|Paid consultant-Atria|Paid consultant-Fabric|Paid consultant-Genome Web|Paid consultant-Genomic Life|Paid consultant-Juniper Genomics|Ownership-Genome Medical|Ownership-Nurture Genomics - 07/26/2023)
Download Handout

AMA PRA Category 1 Credits™ (1.00 hours), ABS CC (1.00 hours), Non-Physician Attendance (1.00 hours), Radiology (1.00 hours)

1. Explore the current state of genomics research and its potential to improve human health through personalized and preventative medicine.
2. Assess whether follow up was appropriate or exaggerated for babies identified with unanticipated monogenic disease risk findings in the BabySeq Project.
3. Discuss the arguments for and against population based genetic screening.
4. Identify the percentages of healthy adults and infants who carry unanticipated monogenic disease risks or atypical pharmacogenomic variants as observed in the MedSeq and BabySeq projects.
5. Explain the difference between indication-based genetic testing and predictive genetic testing.
6. Describe the actions taken for both infants and their families in the BabySeq Project based on unanticipated monogenic disease risks.

Children's Mercy Hospital  designates this live educational activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation.

 

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

Children's Mercy Kansas City reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
Children's Mercy Kansas City is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.